Zobrazeno 1 - 8
of 8
pro vyhledávání: '"David Karanian"'
Autor:
Sarah N. Campion, Christopher J. Bowman, Antje Fuchs, David Karanian, Payal Rana, Gregg D. Cappon
Publikováno v:
Birth defects researchREFERENCES.
Achondroplasia is an autosomal disorder caused by point mutation in the gene encoding fibroblast growth factor receptor 3 (FGFR3) and resulting in gain of function. Recifercept is a potential disease modifying treatment for achondroplasia and functio
Autor:
Kelly R. Bales, Anabella Villalobos, David Riddell, Shawn D. Doran, Christopher Ryan Butler, Bruce N. Rogers, Lorraine F. Lanyon, Karamjeet Pandher, Claude Ambroise, Ashley Robshaw, Gabriela Barreiro, Christopher Houle, Kevin Ogilvie, Brian T. O’Neill, Erik Alphie Lachapelle, Germaine Boucher, Xinjun Hou, Katherine Hales, David Karanian, Michael Aaron Brodney, Leanne M. Buzon, Kimberly Lapham, Lei Zhang, Luis Martinez-Alsina, Charles E. Nolan, Claire M. Steppan, Cathleen Gonzales, John C. Murray, Cheng Chang, Jason K. Dutra, Elizabeth Mary Beck
Publikováno v:
Journal of Medicinal Chemistry. 61:4476-4504
A major challenge in the development of β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors for the treatment of Alzheimer's disease is the alignment of potency, drug-like properties, and selectivity over related aspartyl proteases
Autor:
Michael Aaron Brodney, Michael De Vivo, Ann S. Wright, Stephen Jenkinson, Shawn D. Doran, Patrick Robert Verhoest, Maria S. Brown, Gregory S. Walker, Christopher John Helal, Antonia F. Stepan, Travis T. Wager, R. Scott Obach, Ethan Lawrence Fisher, Tuan P. Tran, Bethany L. Kormos, Raman Sharma, Cheng Chang, Edward X. Yang, Rebecca E. O’Connor, David Karanian
Publikováno v:
ACS Medicinal Chemistry Letters
Late-stage oxidation using liver microsomes was applied to phosphodiesterase 2 inhibitor 1 to reduce its clearance by cytochrome P450 enzymes, introduce renal clearance, and minimize the risk for victim drug–drug interactions. This approach yielded
Autor:
William S. Nowland, Timothy M. Coskran, Elsa G. Barbacci-Tobin, Timothy R. Winton, Steven W. Kumpf, Sarah N. Campion, Robert E. Chapin, Scott Davenport, Christopher Houle, Randal D. Streck, David Karanian
Publikováno v:
Birth Defects Research Part B: Developmental and Reproductive Toxicology. 101:325-332
Treatment-induced epididymal inflammation and granuloma formation is only an occasional problem in preclinical drug development, but it can effectively terminate the development of that candidate molecule. Screening for backup molecules without that
Autor:
Jeffrey W Brulet, Christopher W. am Ende, Michael Aaron Brodney, Sherry Niessen, Brian T. O’Neill, Kevin Atchison, Douglas S. Johnson, Kieran F. Geoghegan, David Riddell, Charles E. Nolan, Elizabeth Mary Beck, Graham M. West, David Karanian, Cheng Chang, Shawn D. Doran, Xinjun Hou, Christopher Houle, Andrea M. Zuhl, Claude Ambroise, Joshua C. Judkins
Publikováno v:
Nature Communications, Vol 7, Iss 1, Pp 1-14 (2016)
Nature Communications
Nature Communications
Inhibition of β-secretase BACE1 is considered one of the most promising approaches for treating Alzheimer's disease. Several structurally distinct BACE1 inhibitors have been withdrawn from development after inducing ocular toxicity in animal models,
Autor:
Kelly R. Bales, David Karanian, Michael Aaron Brodney, Shawn D. Doran, Cathleen Gonzales, Katherine Hales, Germaine Boucher, Lorraine F. Lanyon, Charles E. Nolan, Karamjeet Pandher, Christopher Houle, Claude Ambroise, Cheng Chang
Publikováno v:
Alzheimer's & Dementia. 12
Publikováno v:
Psychopharmacology. 183:41-53
Dopamine signaling in the nucleus accumbens (NAc) plays an important role in regulating drug-taking and drug-seeking behaviors, but the role of D(1)- and D(2)-like receptors in this regulation remains unclear.Our objective was to study the role of NA
Autor:
Robert E, Chapin, Timothy R, Winton, William S, Nowland, Steven W, Kumpf, Scott, Davenport, David, Karanian, Randal D, Streck, Timothy M, Coskran, Elsa G, Barbacci-Tobin, Christopher, Houle, Sarah N, Campion
Publikováno v:
Birth defects research. Part B, Developmental and reproductive toxicology. 101(4)
Treatment-induced epididymal inflammation and granuloma formation is only an occasional problem in preclinical drug development, but it can effectively terminate the development of that candidate molecule. Screening for backup molecules without that